source
- Roche signs $1 billion deal with China’s Rona Therapeutics for RNAi obesity drugRoche announced a new agreement with Chinese biotech Rona Therapeutics to acquire an experimental RNA interference therapy targeting the protein ALK7 for obesity. Under the terms, Roche will pay $…
- Study urges regulators to adopt cloud platforms to speed drug approvalsA new study led by Nina Cauchon of Amgen and co-authors, published in the Journal of Pharmaceutical Sciences, calls for broader use of cloud-based platforms by regulatory agencies. The authors arg…